Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is Volatility Shares 2x Sui ETF (SUIL) ETF Up +19.56% Today?

Why Is Volatility Shares 2x Sui ETF (SUIL) ETF Up +19.56% Today?

Key Takeaways

  • SUIL climbed 19.56% during Thursday's session, rising from a previous close of $10.79 to about $12.90.
  • The move was driven by a powerful short squeeze in the underlying Sui (SUI) token, which surged roughly 20% over 24 hours.
  • The fund provides 2x daily leveraged exposure to Sui through SUI futures contracts, amplifying the token's upside.
  • A bullish technical breakout above the 200-day moving average reinforced buying momentum.
  • Positive ecosystem and regulatory developments—including gasless stablecoin fees and supportive SEC commentary—added to the narrative.
  • Investors are now watching whether Sui can hold its gains and how the leveraged ETF's daily rebalancing affects returns.

Opening Summary

The SUIL ETF—formally the Volatility Shares 2x Sui ETF—surged 19.56% on Thursday, trading near $12.90 after closing the prior session at $10.79. The fund seeks to deliver roughly two times (2x) the daily price movement of the Sui (SUI) cryptocurrency, using cash-settled SUI futures contracts rather than holding the token directly. Today's outsized rally was the direct result of a sharp, short-squeeze-fueled advance in Sui itself, which the fund's leverage amplified.

What Drove the ETF Move Today

A Short Squeeze in Sui

The single most important catalyst was a violent short squeeze in the Sui token. Sui climbed through key price levels during the session, with data from major exchanges showing hundreds of thousands of dollars in short positions liquidated within single-hour windows. As short sellers were forced to buy back their positions, the resulting buying pressure pushed Sui higher in rapid succession, and the leveraged structure of SUIL translated that move into an even larger gain for fund shareholders.

A Bullish Technical Breakout

Sui's rally was reinforced by a technical breakout above its 200-day exponential moving average, a widely watched long-term trend indicator. Once the token cleared this level, momentum traders and systematic strategies added fuel to the advance, contributing to the surge that carried SUIL sharply higher.

Ecosystem and Regulatory Tailwinds

Beyond the price action, the Sui network benefited from a supportive fundamental backdrop. Developers highlighted initiatives such as gasless stablecoin transfers and planned confidential payments, which analysts view as broadening the network's utility for payments and AI-agent transactions. At the same time, more constructive regulatory commentary helped improve sentiment toward the broader digital-asset complex, giving Sui-specific gains a favorable backdrop.

Which Holdings Contributed Most

SUIL does not hold individual stocks. Instead, its performance is driven almost entirely by its SUI futures positions, supported by cash and short-term collateral. Because the fund targets 2x daily exposure, every 1% move in Sui is designed to translate into roughly a 2% move in the fund—before fees and expenses. Today's surge in Sui, itself propelled by short covering and a technical breakout, was therefore the dominant and essentially sole driver of the ETF's gain.

Market Context and Trading Activity

Sui's advance was notably stronger than the broader crypto market. While Sui climbed roughly 20% over 24 hours, peers such as Solana and Ethereum posted more modest single-digit gains, underscoring that this was a Sui-specific, squeeze-driven move rather than a broad risk-on rotation. SUIL is a small, thinly traded fund with roughly $1.3 million in assets, so relatively modest order flow can produce large percentage swings. That structural feature, combined with daily leveraged rebalancing, helps explain the fund's pronounced volatility—its 52-week range spans from $5.00 to $18.20, and it has posted double-digit daily moves on multiple occasions since its May 2026 launch.

What Comes Next for SUIL

The near-term outlook for SUIL hinges heavily on whether Sui can sustain its gains. Key factors investors should monitor include the durability of the technical breakout, the level of remaining short interest, broader crypto market sentiment, and regulatory developments in the United States. Sui's upcoming ecosystem events—including its Basecamp conference in Singapore—could provide additional catalysts or disappoint expectations. Investors should also remember that leveraged, single-day products like SUIL are designed for short-term trading and can suffer from volatility drag and compounding effects when held over multiple sessions, meaning the fund may underperform twice the cumulative move of Sui over longer periods.

Trending AI Robots

For traders seeking a more systematic approach to market volatility, Tickeron's Trending AI Robots page offers a curated selection of AI-driven trading bots. Tickeron provides hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols. Explore the Trending AI Robots page to see which automated strategies are leading right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SUIL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of SUI. The fund does not seek to achieve its stated investment objective over a period of time greater than a single day. Under normal circumstances, the fund will invest at least 80% of the value of its net assets (plus borrowings for investment purposes) in SUI-Linked Instruments. SUI is a digital commodity that is emitted and transmitted through the operations of the delegated proof-of-stake Sui Network, a decentralized network of computers that operates on cryptographic protocols. It is non-diversified.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Miscellaneous
Address
Volatility Shares Trust2000 PGA Blvd, Suite 4400
Phone
N/A
Web
N/A
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Why Is Volatility Shares 2x Sui ETF (SUIL) ETF Up +19.56% Today?